ResMed Valuation

ResMed Inc -- USA Stock  

USD 98.18  0.43  0.44%

ResMed Inc holds recent Real Value of $90.4965 per share. The prevailing price of the company is $98.18. At this time the company appears to be over valued. Macroaxis determines value of ResMed Inc from analyzing the company fundamentals such as Shares Outstanding of 142.93M, Operating Margin of 28.09% and Return On Equity of 15.29% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.

Valuation Drivers Correlation

Selected ResMed Inc Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Market Capitalization    
 Time Horizon     30 Days    Login   to change
ResMed Inc is rated second in beta category among related companies. It is rated fourth in price to earning category among related companies reporting about  39.54  of Price to Earning per Beta.
Over Valued
March 20, 2018
Market Value
Downside upside
Real Value
Target Price Odds
 Above  Below  
Upside upside
ResMed is not too risky asset. Calculation of real value of ResMed Inc is based on 1 month time horizon. Increasing ResMed Inc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.


ResMed Analyst Recommendations
Target PriceAdvice# of Analysts
ResMed Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
ResMed Analyst Advice  

Tax Efficiency

ResMed Inc Tax Efficiency History

Tax Efficiency

Market Capitalization

ResMed Market Capitalization Analysis
ResMed Inc is rated fourth in market capitalization category among related companies. Market capitalization of Medical Equipment industry is at this time estimated at about 110.81 Billion. ResMed retains roughly 14.03 Billion in market capitalization claiming about 13% of all equities under Medical Equipment industry.
Capitalization  Workforce  Valuation  Total debt  Revenue


ResMed Inc Revenue
Based on latest financial disclosure ResMed Inc reported 2.2 B of revenue. This is 66.15% lower than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Revenue for all stocks is 77.66% higher than the company.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.